• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.31% Nasdaq Up0.98%

    SciClone Pharmaceuticals, Inc. (SCLN)

    -NasdaqGS
    7.72 Up 0.32(4.32%) 4:00PM EST
    |After Hours : 7.72 0.00 (0.00%) 4:46PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 127,058   156,269   132,565  
    Cost of Revenue17,668  21,996  19,409  
    Gross Profit 109,390   134,273   113,156  
    Operating Expenses
    Research Development7,463  5,145  12,346  
    Selling General and Administrative90,317  76,249  69,390  
    Non Recurring1,181  43,824   -  
    Others -  2,645  2,465  
    Total Operating Expenses -  127,863   -  
    Operating Income or Loss 10,429   6,410   28,955  
    Income from Continuing Operations
    Total Other Income/Expenses Net2,880  47  50  
    Earnings Before Interest And Taxes13,309  6,457  29,005  
    Interest Expense103  185  213  
    Income Before Tax13,206  6,272  28,792  
    Income Tax Expense2,242  (3,348)670  
    Minority Interest -   -   -  
    Net Income From Continuing Ops10,964  9,620  28,122  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 10,964   9,620   28,122  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 10,964   9,620   28,122  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.